Ortin Global Limited Announces Q3 FY26 Financial Results for Quarter Ended December 31, 2025

1 min read     Updated on 15 Feb 2026, 08:25 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Ortin Global Limited announced its Q3 FY26 unaudited financial results for the quarter ended December 31, 2025, following a board meeting held on February 14, 2026. The results were approved in compliance with SEBI regulations and underwent independent review by Mathesh & Ramana Chartered Accountants. The company, formerly known as Ortin Laboratories Limited, maintains its registered office in Hyderabad and continues to ensure regulatory compliance in its financial reporting.

32712930

*this image is generated using AI for illustrative purposes only.

Ortin Global Limited (formerly known as Ortin Laboratories Limited) has announced its unaudited financial results for the quarter ended December 31, 2025. The announcement follows a board meeting held on February 14, 2026, at the company's registered office in Hyderabad.

Board Meeting Details

The board meeting was conducted on Saturday, February 14, 2026, commencing at 3:00 PM at the company's registered office located at D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad, Hyderabad-500020, Telangana. The meeting concluded at 5:16 PM under the chairmanship of Managing Director S. Murali Krishna Murthy.

Meeting Parameter: Details
Date: February 14, 2026
Start Time: 3:00 PM
End Time: 5:16 PM
Venue: Registered Office, Hyderabad
Chairman: S. Murali Krishna Murthy (DIN: 00540632)

Financial Results Approval

The board considered and approved the unaudited financial results along with the Limited Review Report as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results cover the quarter ended December 31, 2025, and were presented in accordance with applicable accounting standards and recognized accounting practices.

Independent Auditor's Review

The financial results were subject to a limited review by Mathesh & Ramana Chartered Accountants, based in Hyderabad. The independent auditors conducted their review in accordance with Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity," issued by the Institute of Chartered Accountants of India.

The auditors confirmed that nothing came to their attention that would cause them to believe the unaudited financial results were not prepared in accordance with applicable accounting standards or contained any material misstatement. The review was completed on February 14, 2026, by partner B. V. Reddy.

Company Information

Ortin Global Limited, formerly known as Ortin Laboratories Limited, operates under CIN: L68200TG1986PLC006885. The company maintains its registered office in Hyderabad and can be contacted via email at info@ortinlabsindia.com or through their website www.ortinlabsindia.com .

Regulatory Compliance

The announcement was made in compliance with Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has requested the stock exchanges to take note of the financial results disclosure in their records, ensuring transparency and regulatory adherence in its financial reporting process.

Historical Stock Returns for Ortin Global

1 Day5 Days1 Month6 Months1 Year5 Years
+4.98%+29.76%+17.81%+4.41%+1.30%-51.97%

Ortin Global Limited: Parveen Satija Issues Corrigendum to Open Offer Announcement

2 min read     Updated on 11 Feb 2026, 07:55 AM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Mr. Parveen Satija has issued a corrigendum to his February 10, 2026 public announcement regarding the open offer for Ortin Global Limited. The corrigendum clarifies regulatory compliance aspects under SEBI SAST Regulations while maintaining all original offer terms including the ₹14.65 per share price for acquiring 26% stake. All fundamental parameters of the open offer remain unchanged.

32322342

*this image is generated using AI for illustrative purposes only.

Ortin Global Limited's open offer process sees regulatory clarification as Mr. Parveen Satija issues a corrigendum to his original public announcement dated February 10, 2026. The corrigendum, submitted on February 13, 2026, through Rarever Financial Advisors Private Limited, addresses specific regulatory compliance aspects while maintaining all core terms of the original open offer to acquire 26% stake at ₹14.65 per share.

Corrigendum Details and Regulatory Clarifications

The corrigendum specifically clarifies the regulatory framework governing the open offer. Key modifications include updated references to SEBI SAST Regulations and enhanced compliance language:

Modification Area: Updated Details
Regulatory Framework: Regulation 4 read with Regulations 13, 14 and 15(1)
Offer Classification: Triggered Open Offer under Regulation 4
Compliance Basis: SEBI (SAST) Regulations, 2011
Intent Declaration: Acquisition of control of Target Company
Document Date: February 13, 2026

Original Open Offer Terms Remain Unchanged

Despite the regulatory clarifications, all fundamental terms of the open offer continue as originally announced. The acquisition parameters maintain their original structure:

Parameter: Details
Offer Price: ₹14.65 per share
Total Shares Offered: 21,14,162 shares
Percentage of Capital: 26%
Maximum Consideration: ₹3,09,72,473
Payment Mode: Cash
Face Value: ₹10 per share

Triggering Transaction and Share Purchase Agreement

The corrigendum reaffirms that the open offer stems from the Share Purchase Agreement executed on February 10, 2026, between Satija and four promoter sellers. This underlying transaction involves acquisition of 1,00,300 equity shares representing 1.23% of voting capital, valued at ₹14,69,395.

Transaction Aspect: Specification
Triggering Regulation: Regulation 4 of SEBI (SAST) Regulations, 2011
SPA Execution Date: February 10, 2026
Direct Acquisition: 1,00,300 equity shares (1.23%)
Control Intention: Explicitly stated in corrigendum

Manager to the Offer and Documentation

Rarever Financial Advisors Private Limited continues as Manager to the Offer, facilitating all regulatory compliance requirements. The corrigendum bears digital signatures from both Mr. Prasann Bhatt as Authorized Signatory for the Manager and Mr. Parveen Satija as the Acquirer, ensuring proper authorization and accountability.

The document confirms that except for the specific modifications detailed in the corrigendum, all other terms and contents of the original Public Announcement remain unchanged. The corrigendum will be available on SEBI's website at www.sebi.gov.in , ensuring transparency and public accessibility.

Company Profile and Listing Status

Ortin Global Limited maintains its established market presence with dual listing on BSE (Scrip Code: 539287) and NSE (Symbol: ORTINGLOBE). The company's paid-up capital stands at ₹8,13,13,920 with total equity shares of 81,31,392, providing the foundation for the current open offer calculations and regulatory compliance requirements.

Historical Stock Returns for Ortin Global

1 Day5 Days1 Month6 Months1 Year5 Years
+4.98%+29.76%+17.81%+4.41%+1.30%-51.97%

More News on Ortin Global

1 Year Returns:+1.30%